Literature DB >> 2891539

The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro.

E Schön1, S Jahn, S T Kiessig, H U Demuth, K Neubert, A Barth, R Von Baehr, S Ansorge.   

Abstract

Dipeptidyl peptidase IV (DP IV), an ectoenzyme in the cell membrane of T lymphocytes, is an important constituent in the process of lymphocyte activation. This conclusion is drawn from the following observations: (a) Proliferation of peripheral blood lymphocytes induced by mitogenic lectins (phytohemagglutinin, concanavalin A, pokeweed mitogen) is suppressed in the presence of DP IV inhibitors. This effect is specific and applies to an irreversible suicide inhibitor as well as to a competitive one in a dose-dependent fashion. (b) Inhibition of DNA synthesis was also induced by a polyclonal anti-DP IV immunoglobulin. (c) As a consequence of impaired T cell function the production of immunoglobulins by pokeweed mitogen-stimulated lymphocytes is also markedly reduced in the presence of DP IV inhibitors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891539     DOI: 10.1002/eji.1830171222

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.

Authors:  William H Peranteau; Masayuki Endo; Obinna O Adibe; Aziz Merchant; Philip W Zoltick; Alan W Flake
Journal:  Blood       Date:  2006-09-05       Impact factor: 22.113

2.  Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines.

Authors:  D Brömme; A Schierhorn; H Kirschke; B Wiederanders; A Barth; S Fittkau; H U Demuth
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

Review 3.  Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis. A need for analysis on the clonal and molecular level.

Authors:  A Quayle; J Kjeldsen-Kragh; O Førre; K Waalen; M Sioud; C Kalvenes; J B Natvig
Journal:  Springer Semin Immunopathol       Date:  1989

4.  Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.

Authors:  U Lendeckel; T Wex; D Reinhold; T Kähne; K Frank; J Faust; K Neubert; S Ansorge
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

5.  Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.

Authors:  P Ruiz; N Zacharievich; M Shenkin
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

6.  The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

Authors:  T Tanaka; J Kameoka; A Yaron; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  CD26 induces T-cell proliferation by tyrosine protein phosphorylation.

Authors:  E Muñoz; M V Blazquez; J A Madueño; G Rubio; J Peña
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

8.  Involvement of dipeptidyl peptidase IV in an in vivo immune response.

Authors:  T Kubota; G R Flentke; W W Bachovchin; B D Stollar
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

9.  Neuropeptide degrading enzymes in normal and inflamed human synovium.

Authors:  D A Walsh; P I Mapp; J Wharton; J M Polak; D R Blake
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.

Authors:  Kalpit A Vora; Gene Porter; Roche Peng; Yan Cui; Kellyann Pryor; George Eiermann; Dennis M Zaller
Journal:  BMC Immunol       Date:  2009-04-09       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.